Pulmonary Artery Pressure monitoring system for patients with Heart Failure

Inclusion Criteria

• Be 18 years of age or older
• Be NYHA Class III
• Have a heart failure hospitalization within the past 12 month
• Be optimally stable on medical therapy for at least 30 days

Exclusion Criteria

• Have severe valvular disease that requires repair
• Have an active infection
• Have had a major cardiovascular event (e.g., unstable angina, myocardial infarction, percutaneous coronary intervention, open heart surgery, stroke, etc.) within 90 days prior to consent
• Be enrolled in another trial with an active treatment plan

Additional Info

• All patients will be implanted with the CardioMEMS™ device and will have follow-up telephone contacts post-implant at least once every two weeks for the first three months, then monthly until the 12 month follow-up visit. Office visits will occur at 6 and 12 months.
• All treatment and physician visits during this study will take place at Anderson Medical Pavilion and/or Prebys Cardiovascular.
• Search for NCT# 03387813 at www.clinicaltrials.gov for more information
• Study participation will last up to 12 months.